Hu C - Search Results

1

A33 antibody-functionalized exosomes for targeted delivery of doxorubicin against colorectal cancer.

Li Y, Gao Y, Gong C, Wang Z, Xia Q, Gu F, Hu C, Zhang L, Guo H, Gao S. Li Y, et al. Among authors: hu c. Nanomedicine. 2018 Oct;14(7):1973-1985. doi: 10.1016/j.nano.2018.05.020. Epub 2018 Jun 20. Nanomedicine. 2018. PMID: 29935333

2

Reducible self-assembling cationic polypeptide-based micelles mediate co-delivery of doxorubicin and microRNA-34a for androgen-independent prostate cancer therapy.

Yao C, Liu J, Wu X, Tai Z, Gao Y, Zhu Q, Li J, Zhang L, Hu C, Gu F, Gao J, Gao S. Yao C, et al. Among authors: hu c. J Control Release. 2016 Jun 28;232:203-14. doi: 10.1016/j.jconrel.2016.04.034. Epub 2016 Apr 26. J Control Release. 2016. PMID: 27126903

3

Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy.

Chen Z, Tai Z, Gu F, Hu C, Zhu Q, Gao S. Chen Z, et al. Among authors: hu c. Eur J Pharm Biopharm. 2016 Oct;107:130-41. doi: 10.1016/j.ejpb.2016.07.007. Epub 2016 Jul 5. Eur J Pharm Biopharm. 2016. PMID: 27393562

4

Synergistic effect of reduced polypeptide micelle for co-delivery of doxorubicin and TRAIL against drug-resistance in breast cancer.

Hu C, Gu F, Tai Z, Yao C, Gong C, Xia Q, Gao Y, Gao S. Hu C, et al. Oncotarget. 2016 Sep 20;7(38):61832-61844. doi: 10.18632/oncotarget.11451. Oncotarget. 2016. PMID: 27557520 Free PMC article.

5

Tumour microenvironment-responsive lipoic acid nanoparticles for targeted delivery of docetaxel to lung cancer.

Gu F, Hu C, Tai Z, Yao C, Tian J, Zhang L, Xia Q, Gong C, Gao Y, Gao S. Gu F, et al. Among authors: hu c. Sci Rep. 2016 Nov 2;6:36281. doi: 10.1038/srep36281. Sci Rep. 2016. PMID: 27805051 Free PMC article.

6

Co-delivery of autophagy inhibitor ATG7 siRNA and docetaxel for breast cancer treatment.

Gong C, Hu C, Gu F, Xia Q, Yao C, Zhang L, Qiang L, Gao S, Gao Y. Gong C, et al. Among authors: hu c. J Control Release. 2017 Nov 28;266:272-286. doi: 10.1016/j.jconrel.2017.09.042. Epub 2017 Oct 5. J Control Release. 2017. PMID: 28987884

7

Functionalized Multi-Walled Carbon Nanotubes for Targeting Delivery of Immunostimulatory CpG Oligonucleotides Against Prostate Cancer.

Xia Q, Gong C, Gu F, Wang Z, Hu C, Zhang L, Qiang L, Ding X, Gao S, Gao Y. Xia Q, et al. Among authors: hu c. J Biomed Nanotechnol. 2018 Sep 1;14(9):1613-1626. doi: 10.1166/jbn.2018.2605. J Biomed Nanotechnol. 2018. PMID: 29958555

8

Codelivery of miR-4638-5p and Docetaxel Based on Redox-Sensitive Polypeptide Micelles as an Improved Strategy for the Treatment of Castration-Resistant Prostate Cancer.

Jiang W, Gao Y, Wang Z, Gong C, Hu C, Ding X, Qiang L, Gao S, Ren F. Jiang W, et al. Among authors: hu c. Mol Pharm. 2019 Jan 7;16(1):437-447. doi: 10.1021/acs.molpharmaceut.8b01074. Epub 2018 Dec 4. Mol Pharm. 2019. PMID: 30452268

9

Aptamer-conjugated multi-walled carbon nanotubes as a new targeted ultrasound contrast agent for the diagnosis of prostate cancer.

Gu F, Hu C, Xia Q, Gong C, Gao S, Chen Z. Gu F, et al. Among authors: hu c. J Nanopart Res. 2018;20(11):303. doi: 10.1007/s11051-018-4407-z. Epub 2018 Nov 12. J Nanopart Res. 2018. PMID: 30524190 Free PMC article.

10

Co-delivery of the autophagy inhibitor si-Beclin1 and the doxorubicin nano-delivery system for advanced prostate cancer treatment.

Hu C, Gu F, Gong C, Xia Q, Gao Y, Gao S. Hu C, et al. J Biomater Appl. 2022 Feb;36(7):1317-1331. doi: 10.1177/08853282211060252. Epub 2021 Dec 2. J Biomater Appl. 2022. PMID: 34856824

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,468 results

Search Page

Filters